Breaking News, Collaborations & Alliances

Zai Lab, Crescendo Biologics Enter Licensing Agreement

Zai Lab will develop, commercialize, and manufacture a topical antibody VH domain therapeutic for inflammatory indications

Zai Lab Limited and Crescendo Biologics Ltd have entered an exclusive, worldwide licensing agreement under which Zai Lab will develop, commercialize, and manufacture a topical, innovative antibody VH domain therapeutic for potential application in inflammatory indications.  Crescendo Biologic’s product candidate was developed using Crescendo’s transgenic platform, which generates novel small, robust, and potent protein therapeutics based on fully human VH domain building blocks. Zai Lab anti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters